Preferred Label : marstacimab;

UNII : 0UB3OA67O7;

Details


Main resources

You can consult :


https://www.ema.europa.eu/en/medicines/human/EPAR/hympavzi
2025
false
false
false
Netherlands
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
treatment outcome
marstacimab
marstacimab
marstacimab
drug approval
europe
antibodies, monoclonal, humanized
antibodies, monoclonal, humanized
adolescent
adult
hemorrhage
hemophilia B
hemophilia A
injections, subcutaneous
tissue factor pathway inhibitor
risk management
product surveillance, postmarketing
aged
pregnancy
breast feeding
drug evaluation, preclinical

---
https://www.has-sante.fr/jcms/p_3597499/fr/hympavzi-marstacimab-hemophilie
2025
false
false
false
France
hemorrhage
evaluation of the transparency committee
marstacimab
hemophilia A

---
Nous contacter.
24/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.